Technology

Technology

PHASE 1: HA in its original form

PHASE 2: Linearization of the individual HMW* HA chains and process of physical cross-linking

PHASE 3: HMW* HA cross-linking process with BDDE

PHASE 4: Utilization of individual LMW** HA chains and process of physical cross-linking

PHASE 5: Combination of crosslinked LMW** and HMW* HA chains

Technology

MXM® TECHNOLOGY

The AURAFEELTM dermal fillers are manufactured using our patented Modified Cross-linking Matrix (MXM®) technology to create a unique viscoelastic gel with a variable density of hyaluronic acid, which provides an appropriate filling, volumizing and lifting of the skin.

PHASE 1

HA in its original form

PHASE 2

Linearization of the individual HMW* HA chains and process of physical cross-linking

PHASE 3

HMW* HA cross-linking process with BDDE

PHASE 4

Utilization of individual LMW** HA chains and process of physical cross-linking

PHASE 5

Combination of crosslinked LMW** and HMW* HA chains

The highest cross-linking efficiency and safety were gained by inputting the lowest amount of BDDE as a chemical catalyst material. Therefore, a high viscoelastic gel is manufactured.

The rheological properties, including cohesivity, elasticity, and plasticity, will be optimized to match the needs of the targeted layer of the skin.